Josef Smolen, Univ. Prof. Dr.
1 clinical trials · Sponsor
◉ Watch Josef Smolen, Univ. Prof. Dr.
| Record | Firm | Date |
|---|---|---|
| A Study to Target the Type I IFN Receptor by Administrating Anifrolumab in RA Patients With a High IFN Signature (TarIFNiRA) (NCT03435601) | Josef Smolen, Univ. Prof. Dr. | 2018-04-18 |
Track Josef Smolen, Univ. Prof. Dr. automatically
Every clearance here is in the API, with alerts when new ones post.